The Role of Molecular Imaging to Improve Cancer Control Post-Prostatectomy
Peter J. Rossi, MD, a board-certified radiation oncologist affiliated with Calaway Young Cancer Center at Valley View Hospital in Glenwood Springs, Colorado, considers the evidence for using molecular imaging to improve prostate cancer control post-prostatectomy, focusing on the results of the EMPIRE-1 study comparing 18F-fluciclovine-PET/CT imaging versus conventional imaging alone to guide post-prostatectomy salvage radiotherapy for prostate cancer. He explains that the results of this study indicate that approximately ⅓ of patients see changes to their radiotherapy plan based on PET uptake compared to conventional imaging alone, and that these changes result in improved and more durable failure-free survival rates. Dr. Rossi concludes by looking at future directions for research, such as comparing 18F-fluciclovine-PET/CT imaging to PSMA imaging in this setting.
Видео The Role of Molecular Imaging to Improve Cancer Control Post-Prostatectomy канала Grand Rounds in Urology
Видео The Role of Molecular Imaging to Improve Cancer Control Post-Prostatectomy канала Grand Rounds in Urology
Показать
Комментарии отсутствуют
Информация о видео
Другие видео канала
![Accuracy of ExactVu Micro-Ultrasound for Diagnosis of Prostate Cancer](https://i.ytimg.com/vi/YzLLlvt5FQQ/default.jpg)
![Minimally-Invasive Management of Symptomatic Caliceal Diverticular Stones](https://i.ytimg.com/vi/lC_U5Jbf7eo/default.jpg)
![Radiologic Perspective on the Clinical Utility of and Emerging Data on Micro-Ultrasound](https://i.ytimg.com/vi/ZGjSxdGLicc/default.jpg)
![Nephron-Sparing Renal Surgery: Local Recurrence Issues and Preoperative & Postoperative Decisions](https://i.ytimg.com/vi/HF6KOgOjbjE/default.jpg)
![PSMA PET Imaging at Time of Diagnosis](https://i.ytimg.com/vi/_0BXo5FCRYo/default.jpg)
![The ENGAGEMENT Study - Virtual Genetics Board for Improving Prostate Cancer Genetic Testing](https://i.ytimg.com/vi/GZBRPYMQYhc/default.jpg)
![Androgen Targeted Therapy Across the Continuum of Prostate Cancer](https://i.ytimg.com/vi/Dyfv9dotduQ/default.jpg)
![Management of Recurrent Prostate Cancer After Focal Therapy](https://i.ytimg.com/vi/vakQ82M0Nzc/default.jpg)
![Join us for IPCU 33 in Vail CO, January 22-25, 2023](https://i.ytimg.com/vi/mzWgRTdgFLk/default.jpg)
![Case Discussion: Early Detection of Prostate Cancer 2023](https://i.ytimg.com/vi/JiZxLoxksX0/default.jpg)
![The Case for Standard Imaging](https://i.ytimg.com/vi/5FeCgGJKNGA/default.jpg)
![IPCU Session 1 Review: Men's Prostate Health](https://i.ytimg.com/vi/F-vowkpY63M/default.jpg)
![Bottom Line Shrinking? Check Your EOBs](https://i.ytimg.com/vi/tkv6c5OMjRk/default.jpg)
![Socioeconomic Aspects of Prostate Brachytherapy](https://i.ytimg.com/vi/PpfWPcE7KnE/default.jpg)
![Non-Muscle Invasive Bladder Cancer: Guidelines-Based Approach](https://i.ytimg.com/vi/wvodO_0BaXQ/default.jpg)
![Pathologist's Perspective on Focal Therapy](https://i.ytimg.com/vi/xUbElPBr1wQ/default.jpg)
![In My Opinion - The Future of Independent Practice](https://i.ytimg.com/vi/2x_DGPpBMnI/default.jpg)
![Contemporary Management of Recurrent Idiopathic Priapism](https://i.ytimg.com/vi/jQRShNMHLAw/default.jpg)
![Garnick - Review of the New Standard in Treatment and Global Issues](https://i.ytimg.com/vi/4PSyf-YQXVQ/default.jpg)
![PSA Screening in 2023](https://i.ytimg.com/vi/q44jabo1CWY/default.jpg)
![Financial Toxicity](https://i.ytimg.com/vi/wT18d99tOxg/default.jpg)